Eagle raises $1m in funding
To support Eagle Genomics' growth plans, the company has raised $1m within 3 weeks of the launch of its latest investment round, in a first close.
Investors in the round include Newable Private Investing and UK specialist fund UK Innovation & Science Seed Fund (UKI2S – formerly Rainbow Seed Fund), with a follow on investment. The round remains open until the end of June.
The funds raised will be used to accelerate the development of Eagle’s knowledge discovery platform, which transforms scientific data into actionable insights that drive product decision making. The knowledge gained from the platform enables companies to quickly assess product potential, accelerate market entry and mitigate risk.
The funds will also support sales and marketing activity in order to build upon the current momentum.
For more information on Funds, visit https://investment.newable.co.uk/.
Newable Ventures Limited (FRN 795277) is an Appointed Representative of Larpent Newton & Co Ltd. Larpent Newton & Co Ltd is authorised and regulated by the Financial Conduct Authority, FRN 141275.
Neither Newable Capital Limited nor Newable Private Investing Limited are Authorised and Regulated by the Financial Conduct Authority. Risk warning: Your capital is at risk. Investing in early stage companies involves risks including loss of capital, illiquidity, lack of dividends and dilution. Newable Ventures Limited does not give tax or investment advice.
The availability of tax relief depends on individual investors’ circumstances, and on investee companies’ qualifying status, both of which may be subject to change. If you are in doubt about eligibility for tax reliefs or the tax treatment of your investment, you should seek independent tax advice.